NAI Consultant Christopher de Wolff was interviewed on the steps the pharma industry should proactively take to improve its reputation in the article, Devalued and Distrusted: How Can Pharma Rebuild its Image?, published in eyeforpharma.

According to Christopher, restoring their tarnished image “…needs to be a strategic goal set at the level of the CEO, on par with reaching business goals.”

To read Christopher’s recommendations for the industry, see the full eyeforpharma article here.